Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Neuromuscular Electrical Stimulator Treatment in Sepsis/ Septic Shock Patients Protective in the Development of Intensive Care Unit Acquired Muscle Weakness (ICU-AW)?

NCT04833621 is registered in ClinicalTrials.gov with Ondokuz Mayıs University as lead sponsor.

NCT NCT04833621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Neuromuscular Electrical Stimulator Treatment in Sepsis/ Septic Shock Patients Protective in the Development of Intensive Care Unit Acquired Muscle Weakness (ICU-AW)?
Lead sponsor
Ondokuz Mayıs University
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2018
Completion date
October 1, 2020
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care unit acquired weakness, sepsis, severe